Linear cutaneous leishmaniasis occurring on a leg affected by tuberculoid leprosy [3]

British Journal of Dermatology

Volumn 147, Issue 5, 2002, Pages 1022-1023

  Al Aboud, K ^a   Al Hawasawi, K ^a   Ramesh, V ^a   Al Aboud, D ^b   Al Githami, L A ^c  

^a Board of Endodontics in King Faisal Hospital   (Saudi Arabia)

^b Jiad Hospital   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTORY OF MEDICINE; HUMAN; HYPESTHESIA; HYPOPIGMENTATION; LETTER; PRIORITY JOURNAL; SAUDI ARABIA; SKIN LEISHMANIASIS; TUBERCULOID LEPROSY; URINALYSIS;

ADULT; HUMANS; LEG DERMATOSES; LEISHMANIASIS, CUTANEOUS; LEPROSY, TUBERCULOID; MALE;

EID: 0036440665     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.49714.x     Document Type: Letter

References (10)

1. Klaus SN, Frankenburg S, Ingber A. Epidemiology of cutaneous leishmaniasis. Clin Dermatol 1999; 17: 257-60.
2. Barnetson RS, Bryceson AD. Cutaneous leishmaniasis and leprosy. Trans R Soc Trop Med Hyg 1978; 72: 160-3.
3. Torrealba J, Mendoza I, Ocanto T et al. Concomitant cutaneous leishmaniasis and leprosy in Venezuela. Trans R Soc Trop Med Hyg 1995; 89: 69.
4. Gupta PN, Pal NK. Is PGL-1 also present in Leishmania donovani promastigotes? Indian J Lepr 1998; 70: 161-4.
5. Canoune-Herganx F, Gruenheid S, Govani G, Gros P. The Nramp 1 protein and its role in resistance to infection and macrophage function. Proc Assoc Am Phys 1999; 111: 283-9.
6. Pisa P, Gennene M, Soder O et al. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis 1999; 161: 988-91.
7. Rada E, Trujillo D, Castellanos PL, Convit J. Gamma interferon production induced by antigens in patients with leprosy and American cutaneous leishmaniasis. Am J Trop Med Hyg 1987; 37: 520-4.
8. Convit J, Ulrich M, Aranzazu N et al. The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr Rev 1986; 57 (Suppl.): 263-73.
9. Grevelink SA, Lerner E. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-72.
10. Kibbi A-G, Karam PG, Kurban AK. Sporotrichoid leishmaniasis: Clinical and histological features. J Am Acad Dermatol 1987; 17: 759-64.